文献速递青光眼角膜与眼表疾病

0.005%无防腐剂拉坦前列素通过促进炎症诱导小鼠干眼样眼表损伤

0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

该研究在小鼠中局部应用0.005%无防腐剂拉坦前列素或溶媒14至28天,发现拉坦前列素降低泪液分泌、导致结膜杯状细胞丢失、破坏角膜上皮屏障并促进眼表细胞凋亡。机制上,拉坦前列素增加角膜上皮MMP-3和MMP-9表达、降低ZO-1和occludin-1表达,并激活结膜P38-NF-κB信号、促进CD4+ T细胞浸润及炎症因子产生。结论认为0.005%拉坦前列素通过促进炎症诱导小鼠干眼样眼表损伤。

要点

  • 无防腐剂0.005%拉坦前列素可降低小鼠泪液分泌并导致结膜杯状细胞丢失。
  • 拉坦前列素破坏角膜上皮屏障,增加MMP-3/9并降低ZO-1和occludin-1。
  • 拉坦前列素激活结膜P38-NF-κB信号并促进CD4+ T细胞相关炎症。

核心结论

  • 0.005%拉坦前列素通过促进炎症在小鼠中诱导干眼样眼表损伤。

研究设计与样本

  • 在小鼠中局部应用0.005%拉坦前列素或溶媒,采用两种模式处理14至28天。
  • 通过酚红棉线试验测泪液分泌,OGD染色评估角膜上皮屏障功能,PAS染色定量结膜杯状细胞。
  • 通过免疫荧光和/或qRT-PCR评估角膜上皮MMP-3、MMP-9、occludin-1和ZO-1表达。
  • 通过P38和NF-κB活化、CD4+ T细胞浸润及炎症因子产生评估结膜炎症。
  • 通过TUNEL及活化caspase-3和caspase-8免疫荧光评估眼表凋亡,并在人角膜上皮细胞中进行细胞活力测定。

主要发现

  • 局部拉坦前列素处理降低泪液分泌、诱导结膜杯状细胞丢失、破坏角膜上皮屏障并促进眼表细胞凋亡。
  • 局部拉坦前列素处理增加角膜上皮MMP-3和MMP-9表达,降低ZO-1和occludin-1表达。
  • 局部拉坦前列素促进结膜P38-NF-κB信号活化及TNF-α和IL-1β产生。
  • 局部拉坦前列素增加结膜CD4+ T细胞浸润,伴IFN-γ和IL-17A产生增加、IL-13产生减少。

临床怎么用

  • 使用无防腐剂0.005%拉坦前列素时需关注泪液分泌减少、杯状细胞丢失和角膜上皮屏障破坏等眼表损伤迹象。
  • 对于已有眼表炎症或干眼风险的患者,应留意拉坦前列素可能通过P38-NF-κB及CD4+ T细胞相关炎症加重眼表损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the side effects of preservative-free 0.005% latanoprost on the murine ocular surface. METHODS: We applied 0.005% latanoprost or vehicle in mice in two patterns for 14 to 28 days. Tear production was measured by phenol red cotton test, and corneal epithelial barrier function was assessed by Oregon-green-dextran (OGD) staining. Periodic acid-Schiff (PAS) staining was used to quantify conjunctival goblet cells (GCs). The expression of matrix metalloproteinase (MMP)-3 and -9, occludin-1 and zonula occludens (ZO)-1 in corneal epithelium was assessed by immunofluorescent staining and/or quantitative real-time PCR (qRT-PCR). Inflammation in conjunctiva was assessed by activation of P38 and NF-κB, infiltration of CD4+ T cells, and production inflammatory cytokines including TNF-α, IL-1β, IFN-γ, IL-17A, and IL-13. Apoptosis in ocular surface was assessed by TUNEL and immunofluorescent staining for activated caspase-3 and -8. Cell viability assay was performed in human corneal epithelial cells. RESULTS: Topical latanoprost treatment decreased tear production, induced conjunctival GC loss, disrupted the corneal epithelial barrier, and promoted cell apoptosis in the ocular surface. Topical latanoprost treatment increased the expression of MMP-3 and -9, and decreased the expression of ZO-1 and occludin-1 in the corneal epithelium. Topical application of latanoprost promoted activation of P38-NF-κB signaling and production of TNF-α and IL-1β in conjunctiva. Topical application of latanoprost increased CD4+ T cells infiltration, with increased production of IFN-γ and IL-17A and decreased production of IL-13 in conjunctiva. CONCLUSION: 0.005% latanoprost induced dry eye-like ocular surface damage via promotion of inflammation in mice.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Yang Y, Huang C, Lin X, et al. 0.005% Preservative-Free Latanoprost Induces Dry Eye-Like Ocular Surface Damage via Promotion of Inflammation in Mice. Invest Ophthalmol Vis Sci. 2018. PMID: 30025085. doi:10.1167/iovs.18-24013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。